AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Bottom 13%
#4634 out of 5290 analysts
Average Return
-3.43%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-13 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-09 - 2025-01-08 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-12 - 2024-01-11 | Strong Buy |
Procept Biorobotics CorpPRCT | +17.77% | $23.63 | $27.83 | 2026-02-26 - 2026-06-05 | Strong Buy |
Nevro CorpNVRO | +11.80% | $4.83 | $4.26 | 2024-08-07 - 2024-12-03 | Strong Sell |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lemaitre Vascular IncLMAT | 4 | Hold | $104.00 | +10.08% | Maintains | a month ago |
Irhythm Holdings IncIRTC | 8 | Strong Buy | $180.00 | +66.50% | Maintains | a month ago |
Resmed IncRMD | 3 | Hold | $227.00 | +15.79% | Maintains | a month ago |
Procept Biorobotics CorpPRCT | 10 | Strong Buy | $34.00 | +22.17% | Maintains | 3 months ago |
Integer Holdings CorpITGR | 5 | Hold | $84.00 | -8.68% | Maintains | 4 months ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.